Antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2002

被引:22
作者
Lee, SJ
Lee, SD
Cho, IR
Sim, BS
Lee, JG
Kim, CS
Kim, ME
Cho, YH
Woo, YN
机构
[1] Catholic Univ, Dept Urol, St Marys Hosp, Seoul 150713, South Korea
[2] Korean Assoc Urogenital Tract Infect, Seoul, South Korea
[3] Hanyang Univ, Seoul 133791, South Korea
关键词
antimicrobial susceptibility; uncomplicated cystitis; ciprofloxacin; trimethoprim/sulphamethoxazole;
D O I
10.1016/j.ijantimicag.2004.02.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The objective of this study was to obtain data on the susceptibility of pathogens responsible for acute uncomplicated cystitis in South Korea to currently used antimicrobial agents. A total of 239 isolates were obtained from female outpatients with acute uncomplicated cystitis. The most prevalent causative organism was Escherichia coli (79.9%), followed by coagulase-negative staphylococci (CNS) (4.2%) and Enterobacteriaceae (8.2%). The mean rates of susceptibility to commonly prescribed drugs are ampicillin 35.5%, cefazolin 89.1%, ciprofloxacin 85.7%, and trimethoprim/sulphamethoxazole (TMP/SMX) 62.1%. Regionally, resistance to TMP/SMX among E. coli now exceeds 30% in all regions. The high prevalence of resistance among uropathogens requires on going surveillance to ensure the provision of effective empirical therapy for acute uncomplicated cystitis. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:S61 / S64
页数:4
相关论文
共 10 条
[1]  
Dyer IE, 1998, WESTERN J MED, V169, P265
[2]   Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women [J].
Gupta, K ;
Scholes, U ;
Stamm, WE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (08) :736-738
[3]   Diagnosis and treatment of uncomplicated urinary tract infection [J].
Hooton, TM ;
Stamm, WE .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (03) :551-+
[4]   Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland [J].
Hryniewicz, K ;
Szczypa, K ;
Sulikowska, A ;
Jankowski, K ;
Betlejewska, K ;
Hryniewicz, W .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (06) :773-780
[5]   Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999 [J].
Karlowsky, JA ;
Jones, ME ;
Thornsberry, C ;
Critchley, I ;
Kelly, LJ ;
Sahm, DF .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (02) :121-127
[6]  
KUNIN C, 1997, URINART TRACT INFECT
[7]   Urinary tract infection in adults: research priorities and strategies [J].
Ronald, AR ;
Nicolle, LE ;
Stamm, E ;
Krieger, J ;
Warren, J ;
Schaeffer, A ;
Naber, KG ;
Hooton, TM ;
Johnson, J ;
Chambers, S ;
Andriole, V .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (04) :343-348
[8]   Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999 [J].
Turnidge, J ;
Bell, J ;
Biedenbach, DJ ;
Jones, RN .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (01) :10-17
[9]   Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women [J].
Warren, JW ;
Abrutyn, E ;
Hebel, JR ;
Johnson, JR ;
Schaeffer, AJ ;
Stamm, WE .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (04) :745-758
[10]   A Canadian national surveillance study of urinary tract isolates from outpatients: Comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin [J].
Zhanel, GG ;
Karlowsky, JA ;
Harding, GKM ;
Carrie, A ;
Mazzulli, T ;
Low, DE ;
Hoban, DJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :1089-1092